Isabelle Borget

Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

Martin Schlumberger, Bogdan Catargi, Isabelle Borget et al. · New England Journal of Medicine · 2012 · 692 citations · Full text

Medicine, Oncology, Surgery +16

Detection of Circulating Tumor Cells Harboring a Unique <i>ALK</i> Rearrangement in <i>ALK</i>-Positive Non–Small-Cell Lung Cancer

Emma Pailler, Julien Adam, Amélie Barthelemy et al. · Journal of Clinical Oncology · 2013 · 280 citations · Full text

Medicine, Genetics, Oncology +17

Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study

Rossella Libé, Isabelle Borget, Cristina L. Ronchi et al. · Annals of Oncology · 2015 · 255 citations · Full text

Medicine, Endocrinology, Oncology +14

A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)

Karim Fizazi, Aline Maillard, Nicolas Penel et al. · Annals of Oncology · 2019 · 247 citations · Full text

Medicine, Oncology, Pharmacology +16

Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients

Maryse Brassard, Isabelle Borget, Agathe Edet‐Sanson et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 232 citations · Full text

Medicine, Endocrinology, Surgery +17